Subscribe to Newsletter

Search

Reset Filter

4110 search results for ‘*’

Discovery & Development Drug Discovery

Addressing Alzheimer’s

| 3 min read

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

Discovery & Development Drug Discovery

Alzheimer’s Treatment Timeline

| Stephanie Vine | 2 min read

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

Discovery & Development Drug Discovery

Fabulously Interesting

| 6 min read

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

Business & Regulation Standards & Regulation

FDA Warning Letters: September 2023 Edition

| Stephanie Vine | 4 min read

A look at cGMP deviations in recent warning letters, including manufacturing conducted in corridors and equipment uncleaned for 14 years.

Manufacture Bioprocessing - Upstream & Downstream

The Viral Frontier

| Natalia Elizalde | 3 min read

How can companies beat the bottlenecks in viral vector manufacturing?

Manufacture Process Control

Rent to Reduce

| Stephen Harding | 3 min read

Is renting material handling equipment the best way to help manufacturers tackle waste?

Business & Regulation Trends & Forecasts

The Battle Outside Raging

| Rob Coker | 2 min read

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

Discovery & Development Clinical Trials

Ignaz Semmelweis, We Salute You

| Rob Coker | 4 min read

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

Manufacture Trends & Forecasts

ECOnti: Sustainable Steps Towards Continuous Processes

| Sponsored by Tosoh | 7 min read

How Tosoh Biosciences is contributing to a fascinating project on a mission to develop a continuous production process using Escherichia Coli

Discovery & Development Drug Discovery

Llamas Versus Dengue

| Stephanie Vine | 3 min read

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register